Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Resnick

Showing results (1-10 of 506) with videos related to

Pageof 51
Sort By:
JAMA Neurology|September 16, 2014
Preclinical biomarkers in Alzheimer disease: a sum greater than the partsSusan M Resnick
Current Alzheimer Research|February 24, 2007
Testosterone and cognition in normal aging and Alzheimer's disease: an updateIra Driscoll, Susan M Resnick
Neurobiology of Aging|March 12, 2004
Aging and prefrontal functions: dissociating orbitofrontal and dorsolateral abilitiesMelissa Lamar, Susan M Resnick
Cerebral Cortex (New York, N.Y. : 1991)|June 7, 2002
Degenerative age changes in white matter connectivity visualized in vivo using magnetic resonance imagingChristos Davatzikos, Susan M Resnick
Alzheimer'S Research & Therapy|February 25, 2011
Amyloid imaging and memory change for prediction of cognitive impairmentSusan M Resnick, Jitka Sojkova
Neurology|December 23, 2011
MRI-based biomarkers of preclinical AD: an Alzheimer signatureSusan M Resnick, Philip Scheltens
Biological Psychiatry|April 18, 2020
Amyloid Positivity as a Risk Factor for Memory Decline and Lower Memory Performance as an Indicator of Conversion to Amyloid Positivity: Chicken and EggMurat Bilgel, Susan M Resnick
Neurobiology of Aging|May 16, 2006
Long-term measures of free testosterone predict regional cerebral blood flow patterns in elderly menScott D Moffat, Susan M Resnick
JAMA|November 7, 2002
Hormone therapy and risk of Alzheimer disease: a critical timeSusan M Resnick, Victor W Henderson
Hormones and Behavior|May 4, 2015
Postmenopausal hormone therapy and cognitionAnna C McCarrey, Susan M Resnick
Pageof 51

Showing results (1-10 of 506) with videos related to

Sort By:
Pageof 51
JAMA Neurology|September 16, 2014
Preclinical biomarkers in Alzheimer disease: a sum greater than the partsSusan M Resnick
Current Alzheimer Research|February 24, 2007
Testosterone and cognition in normal aging and Alzheimer's disease: an updateIra Driscoll, Susan M Resnick
Neurobiology of Aging|March 12, 2004
Aging and prefrontal functions: dissociating orbitofrontal and dorsolateral abilitiesMelissa Lamar, Susan M Resnick
Cerebral Cortex (New York, N.Y. : 1991)|June 7, 2002
Degenerative age changes in white matter connectivity visualized in vivo using magnetic resonance imagingChristos Davatzikos, Susan M Resnick
Alzheimer'S Research & Therapy|February 25, 2011
Amyloid imaging and memory change for prediction of cognitive impairmentSusan M Resnick, Jitka Sojkova
Neurology|December 23, 2011
MRI-based biomarkers of preclinical AD: an Alzheimer signatureSusan M Resnick, Philip Scheltens
Biological Psychiatry|April 18, 2020
Amyloid Positivity as a Risk Factor for Memory Decline and Lower Memory Performance as an Indicator of Conversion to Amyloid Positivity: Chicken and EggMurat Bilgel, Susan M Resnick
Neurobiology of Aging|May 16, 2006
Long-term measures of free testosterone predict regional cerebral blood flow patterns in elderly menScott D Moffat, Susan M Resnick
JAMA|November 7, 2002
Hormone therapy and risk of Alzheimer disease: a critical timeSusan M Resnick, Victor W Henderson
Hormones and Behavior|May 4, 2015
Postmenopausal hormone therapy and cognitionAnna C McCarrey, Susan M Resnick
Pageof 51